Immune Checkpoints and Beyond I

Moderator(s)

• JA

  Judith Agudo

  Associate Professor
  Dana-Farber Cancer Institute
  Boston, Massachusetts, United States
• JL

  Judith Lieberman

  Boston Childrens

Presentations:

• 4:15 PM - 4:30 PM US ET

  Oncolytic HSV-1 Encoding IL-12 and Anti-PD-1 Reprograms CNS Immunity: Open-Label Study of MVR-C5252 for Safety, Tolerability, and Efficacy (PuMP)
  

  Author: Elizabeth Owens, B.S. (she/her/hers) – Duke Univ. Sch. of Med.
• 4:30 PM - 4:45 PM US ET

  Opposing Effects of Metoclopramide and Bromocriptine on Melanoma Response to Immune Checkpoint Blockade
  

  Author: Mark Gregory, MS – Karmanos Cancer Inst., Wayne State Univ.
• 4:45 PM - 5:00 PM US ET

  Myoglobin expression boosts T-cell metabolism and antitumor effector function
  

  Author: Julia Werner, M.Sc. (she/her/hers) – Heinrich Heine University Düsseldorf
• 5:00 PM - 5:15 PM US ET

  Skin mites enhance virtual memory T cell responses against immune checkpoint inhibitor-resistant tumors
  

  Author: Jihoon Oh, PhD (he/him/his) – National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
• 5:15 PM - 5:30 PM US ET

  Targeting glycans for cancer immunotherapy
  

  Author: Jessica Stark, PhD (she/her/hers) – Massachusetts Institute of Technology
• 5:30 PM - 5:45 PM US ET

  Leveraging extrafollicular B cells for the treatment of solid tumors
  

  Author: Allison Casey, BS – University of Pittsburgh